• Explore /
  • Poster
  • / Genetic variants in methylation and demethylation pathways to predict clinical outcome in metastatic colorectal cancer (mCRC) patients (pts) treated with first-line FOLFIRI/Bev: Data from TRIBE and FIRE-3 trials.

Genetic variants in methylation and demethylation pathways to predict clinical outcome in metastatic colorectal cancer (mCRC) patients (pts) treated with first-line FOLFIRI/Bev: Data from TRIBE and FIRE-3 trials.

Abstract Poster

Authors

Alberto Puccini

Alberto Puccini

USC Keck School of Medicine, Los Angeles, CA

Alberto Puccini , Fotios Loupakis , Sebastian Stintzing , Martin D. Berger , Ryuma Tokunaga , Madiha Naseem , FRANCESCA BATTAGLIN , Shu Cao , Joshua Millstein , Shivani Soni , Michelle McSkane , Wu Zhang , Volker Heinemann , Alfredo Falcone , Heinz-Josef Lenz

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Cancers of the Colon, Rectum, and Anus

Track

Cancers of the Colon, Rectum, and Anus

Sub Track

Translational Research

Citation

J Clin Oncol 36, 2018 (suppl 4S; abstr 646)

DOI

10.1200/JCO.2018.36.4_suppl.646

Abstract #

646

Poster Bd #

E7

Abstract Disclosures

Similar Posters

First Author: Madiha Naseem

First Author: Alberto Puccini

First Author: Yu Sunakawa

First Author: Anish Parekh